Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults

400 mg (2 × 200 mg tablets) orally twice daily

60 mg/m\^2 administered intravenously daily on Days 1 to 3 of each 28-day induction cycle

"100 mg/m\^2 intravenous administration twice daily on Days 1 to 7 of each 28-day induction cycle~Hi-DAC: 3 g/m\^2 IV administration twice daily on days 1, 3, and 5 (≤ 60 years of age) or 1 g/m\^2 IV administration once daily on Days 1 to 5 (\> 60 years of age) of each 28-day post-remission cycle"